1
|
Moore U, de Almeida Araujo EC, Reyngoudt H, Gordish-Dressman H, Smith F, Wilson J, James M, Mayhew A, Rufibach L, Stojkovic T, Blamire A, Straub V, Carlier P, Manera JD. P.165 Clinical outcome study of dysferlinopathy: Lower limb water T2 predicts functional decline in patients with dysferlinopathy. Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.303] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
2
|
Moat D, McCallum M, Muni-Lofra R, Wong K, Michell-Sodhi J, James M, Michura D, Richardson M, Carden G, Hall C, Frith K, Fitzsimmons S, Marini-Bettolo C, Mayhew A. FP.25 Contracture management in ambulant boys with Duchenne muscular dystrophy (DMD). Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
3
|
James M, Dressman HG, Hilsden H, Rufibach L, Human A, Duong T, Maron E, DeWolf B, Rose K, Siener C, Thiele S, Práxedes NSA, Canal A, Holsten S, Sakamoto C, Pedrosa-Hernández I, Bello L, Alfano L, Lowes LP, Straub V, Mayhew A. P.162 Clinical outcome study of dysferlinopathy: Performance of upper limb entry item to predict forced vital capacity in dysferlinopathy (LGMDR2). Neuromuscul Disord 2022. [DOI: 10.1016/j.nmd.2022.07.300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
|
4
|
Narayan S, Pietrusz A, Allen J, Docherty K, Emery N, Ennis M, Flesher R, Foo W, Freebody J, Gallagher E, Grose N, Harris D, Hewamadduma C, Holmes S, James M, Maidment L, Mayhew A, Moat D, Moorcroft N, Muni-Lofra R, Nevin K, Quinlivan R, Sodhi J, Stuart D, White N, Yvonne J. Adult North Star Network (ANSN): Consensus Document for Therapists Working with Adults with Duchenne Muscular Dystrophy (DMD) - Therapy Guidelines. J Neuromuscul Dis 2022; 9:365-381. [PMID: 35124658 DOI: 10.3233/jnd-210707] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- S Narayan
- University Hospital Southampton NHS Foundation Trust, Southampton SO16 6YD, UK
| | - A Pietrusz
- UCL Queen Square Institute of Neurology, MRC Centre for Neuromuscular Diseases, UK
| | - J Allen
- Neuromuscular Complex Care Centre (NMCCC), National Hospital for Neurology and Neurosurgery, UK
| | - K Docherty
- University Hospitals Dorset NHS Foundation Trust, UK
| | - N Emery
- The Robert Jones and Agnes Hunt Orthopaedic Hospital, UK
| | - M Ennis
- The Walton Centre NHS Foundation Trust, UK
| | - R Flesher
- The Walton Centre NHS Foundation Trust, UK
| | - W Foo
- Manchester University NHS Foundation Trust, UK
| | - J Freebody
- John Radcliffe Hospital -OxfordUniversity Hospitals NHS Foundation Trust, UK
| | | | - N Grose
- North Bristol NHS Foundation Trust, The South West Neuromuscular Operational Delivery Network (SWNODN), UK
| | - D Harris
- West Midlands Rehabilitation Centre, Birmingham Community Healthcare NHS Foundation Trust, UK
| | - C Hewamadduma
- Sheffield Teaching Hospitals NHS Foundation Trust, UK.,Sheffield Institute for Translational Neurosciences (SITRAN), University of Sheffield, UK
| | - S Holmes
- MRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, UK
| | - M James
- The John Walton Muscular Dystrophy Research Centre, Newcastle, UK
| | - L Maidment
- Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - A Mayhew
- The John Walton Muscular Dystrophy Research Centre, Newcastle, UK
| | - D Moat
- The John Walton Muscular Dystrophy Research Centre, Newcastle, UK
| | - N Moorcroft
- West Midlands Rehabilitation Centre, Birmingham Community Healthcare NHS Foundation Trust, UK
| | - R Muni-Lofra
- The John Walton Muscular Dystrophy Research Centre, Newcastle, UK
| | - K Nevin
- Sheffield Teaching Hospitals NHS Foundation Trust, UK
| | - R Quinlivan
- UCL Queen Square Institute of Neurology, MRC Centre for Neuromuscular Diseases, UK
| | - J Sodhi
- The John Walton Muscular Dystrophy Research Centre, Newcastle, UK
| | | | - N White
- The Robert Jones and Agnes Hunt Orthopaedic Hospital, UK
| | - J Yvonne
- University Hospitals of Leicester Emergency and Specialist Medicine, UK
| | | |
Collapse
|
5
|
Muni-Lofra R, Murphy L, Adcock K, Farrugia M, Irwin J, Lilleker J, McConville J, Merrison A, Parton M, Ryburn L, Scoto M, Marini-Bettolo C, Mayhew A. SMA – OUTCOME MEASURES AND REGISTRIES. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
6
|
Moore U, James M, Spuler S, Day J, Jones K, Bharucha-Goebel D, Salort-Campana E, Pestronk A, Walter M, Paradas C, Stojkovic T, Yoshimura MM, Bravver E, Pegoraro E, Mendell J, Bushby K, Straub V, Mayhew A. LGMD. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
7
|
James M, Alcock L, Straub V, Mayhew A. LGMD. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Schiava M, Amos R, VanRuiten H, McDermott M, Martens W, Gregory S, Mayhew A, McColl E, Tawil R, Willis T, Bushby K, Griggs R, Guglieri M & the FOR DMD group. DMD/BMD - GENETICS. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Pietrusz A, Guglieri M, Astin R, Desikan M, Muni-Lofra R, Mayhew A, Waller K, Chapman S, Ramdharry G, Quinlivan R. DMD – CLINICAL CARE. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
10
|
Moore U, Gordish H, Maneraz JD, James M, Mayhew A, Guglieri M, Spuler S, Day J, Jones K, Bharucha-Goebel D, Salort-Campana E, Pestronk A, Walter M, Paradas C, Stojkovic T, Yoshimura M, Bravver E, Pegoraro E, Mendell J, Straub V. FROM THE SPINAL CORD TO THE MUSCLE. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Muni-Lofra R, Coratti G, Ramsey D, Moat D, Sodhi J, James M, D'Amico A, Scoto M, Pane M, Bertini E, Marini-Bettolo C, Muntoni F, Mercuri E, Mayhew A. SMA - CLINICAL. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Alfano L, James M, Miller N, Muni-Lofra R, Iammarino M, Moat D, Powers B, Sodhi J, McCallum M, Shannon K, Eagle M, Mayhew A, Lowes L. OUTCOME MEASURES. Neuromuscul Disord 2020. [DOI: 10.1016/j.nmd.2020.08.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
13
|
Ramsey D, Scoto M, Mayhew A, Muni Lofra R, Main M, Milev E, Mazzone E, Montes J, Glanzman A, Pasternak A, Duong T, Civitello M, Coratti G, Straub V, Day J, Darras B, De Vivo D, Finkel R, Mercuri E, Muntoni F. P.220The revised Hammersmith scale (RHS) for spinal muscular atrophy: longitudinal trajectories in a large international cohort of patients with type 2 and 3 SMA. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
14
|
Mayhew A, James M, Hilsden H, Sutherland H, Jacobs M, Spuler S, Day J, Jones K, Bharucha-Goebel D, Salort-Campana E, Pestronk A, Walter M, Paradas C, Stojkovic T, Mori-Yoshimura M, Bravver E, Diaz Manera J, Pegoraro E, Mendell J, Rufibach L, Straub V. P.177Measuring what matters in dysferlinopathy – linking functional ability to patient reported outcome measures. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
15
|
McCallum M, Mayhew A, Moat D, Sodhi J, James M, Specht S, Guglieri M, Straub V, Marini-Bettolo C, Muni-Lofra R. EP.52Overnight pulse oximetry for respiratory progression screening in a neuromuscular service. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.284] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
16
|
Moat D, McCallum M, James M, Sodhi J, Hall C, Marini-Bettolo C, Muni-Lofra R, Mayhew A. EP.50A service evaluation of orthotic provision for neuromuscular patients at the John Walton neuromuscular research centre. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
17
|
Moore U, James M, Jacobs M, Mayhew A, Spuler S, Day J, Bharucha-Goebel D, Stojkovic T, Mendell J, Straub V. P.188The clinical outcome study for dysferlinopathy: pregnancy in dysferlinopathy. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.243] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
18
|
Messina S, Frongia A, Antonaci L, Pera M, Coratti G, Pane M, Mayhew A, Pasternak A, Civitello M, Finkel R, Muntoni F, Mercuri E. EP.55A critical review of tools assessing health related quality of life, activity of daily living and caregiver burden in SMA. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
19
|
James M, Fernández-Torrón R, Mayhew A, Alfano L, Muni-Lofra R, Duong T, Maron E, Hutchence M, Vandervelde B, Mendez B, Holsten S, Sakamoto C, Pedrosa Belmonte I, Thiele S, Canal A, Semplicini C, Seiner C, Lowes L, Straub V, Diaz-Manera J. P.184Clinical outcome study for dysferlinopathy: a longitudinal examination of the upper limb involvement using physiotherapy outcome measures and T1w MRI. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
20
|
James M, Smith F, Reyngoudt H, Wilson I, Mayhew A, Fernández-Torrón R, Araujo E, Stojkovic T, Blamire A, Carlier P, Straub V. P.185The clinical outcome study for dysferlinopathy: quantitative MRI and physiotherapy outcomes to capture disease progression. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
21
|
Ricotti V, Selby V, Ridout D, Domingos J, Decostre V, Mayhew A, Eagle M, Butler J, Guglieri M, Van der Holst M, Jansen M, Verschuuren JJGM, de Groot IJM, Niks EH, Servais L, Straub V, Voit T, Hogrel JY, Muntoni F. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study. Neuromuscul Disord 2019; 29:261-268. [PMID: 30852071 DOI: 10.1016/j.nmd.2019.02.002] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2018] [Revised: 02/05/2019] [Accepted: 02/08/2019] [Indexed: 11/19/2022]
Abstract
The field of translational research in Duchenne muscular dystrophy (DMD) has been transformed in the last decade by a number of therapeutic targets, mostly studied in ambulant patients. A paucity of studies focus on measures that capture the non-ambulant stage of the disease, and the transition between the ambulant and non-ambulant phase. In this prospective natural history study, we report the results of a comprehensive assessment of respiratory, upper limb function and upper limb muscle strength in a group of 89 DMD boys followed in 3 European countries, 81 receiving corticosteroids, spanning a wide age range (5-18 years) and functional abilities, from ambulant (n = 60) to non-ambulant (n = 29). Respiratory decline could be detected in the early ambulatory phase using Peak Expiratory Flow percentage predicted (PEF%), despite glucocorticoid use (mean annual decline: 4.08, 95% CI [-7.44,-0.72], p = 0.02 in ambulant; 4.81, 95% CI [-6.79,-2.82], p < 0.001 in non-ambulant). FVC% captured disease progression in non-ambulant DMD subjects, with an annual loss of 5.47% (95% CI [-6.48,-4.45], p < 0.001). Upper limb function measured with the Performance of Upper Limb (PUL 1.2) showed an annual loss of 4.13 points (95% CI [-4.79,3.47], p < 0.001) in the non-ambulant cohort. Measures of upper limb strength (MyoGrip and MyoPinch) showed a continuous decline independent of the ambulatory status, when reported as percentage predicted (grip force -5.51%, 95% CI [-6.54,-4.48], p < 0.001 in ambulant and a slower decline -2.86%; 95% CI -3.29,-2.43, p < 0.001, in non-ambulant; pinch force: -2.66%, 95% CI [-3.82,-1.51], p < 0.001 in ambulant and -2.23%, 95% CI [-2.92,-1.53], p < 0.001 in non-ambulant). Furthermore, we also explored the novel concept of a composite endpoint by combining respiratory, upper limb function and force domains: we were able to identify clear clinical progression in patients in whom an isolated measurement of only one of these domains failed to appreciate the yearly change. Our study contributes to the field of natural history of DMD, linking the ambulant and non-ambulant phases of the disease, and suggests that composite scores should be explored further.
Collapse
Affiliation(s)
- V Ricotti
- NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, University College London, London, UK; Solid Biosciences, London, UK.
| | - V Selby
- NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, University College London, London, UK; Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, London, UK
| | - D Ridout
- NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, University College London, London, UK; Population, Policy and Practice Program, UCL Great Ormond Street Institute of Child Health, London, UK
| | - J Domingos
- Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, London, UK
| | - V Decostre
- Groupe Hospitalier Pitié Salpêtrière, Institut de Myologie, Paris, France
| | - A Mayhew
- John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle, UK
| | - M Eagle
- John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle, UK
| | - J Butler
- Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, London, UK
| | - M Guglieri
- John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle, UK
| | | | - M Jansen
- Department of Rehabilitation, Donders Centre of Neuroscience, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
| | | | - I J M de Groot
- Department of Rehabilitation, Donders Centre of Neuroscience, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
| | - E H Niks
- Leiden University Medical Centre, Leiden, The Netherlands
| | - L Servais
- Groupe Hospitalier Pitié Salpêtrière, Institut de Myologie, Paris, France
| | - V Straub
- John Walton Muscular Dystrophy Research Centre, Newcastle University, Newcastle, UK
| | - T Voit
- NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, University College London, London, UK; Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, London, UK
| | - J Y Hogrel
- Groupe Hospitalier Pitié Salpêtrière, Institut de Myologie, Paris, France
| | - F Muntoni
- NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, University College London, London, UK; Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital Trust, London, UK.
| |
Collapse
|
22
|
Miller N, Lowes L, James M, Alfano L, Mayhew A, Maron E, Gee R, Harman M, Duong T, Vandervelde B, Siener C, Thiele S, Mendez B, Canal A, Sakamoto C, Holsten S, Pedrosa Belmonte I, Semplicini C, Straub V. LIMB-GIRDLE MUSCULAR DYSTROPHY I. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
23
|
Muntoni F, Manzur A, Mayhew A, Signorovitch J, Sajeev G, Yao Z, Dieye I, Jenkins M, Ward S. DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.347] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
24
|
Pitchforth J, Domingos J, Iodice M, Mayhew A, Muntoni F. DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
25
|
Fernandez-Torron R, Diaz-Manera J, James M, Mayhew A, Spuler S, Day J, Jones K, Bharucha-Goebel D, Salort-Campana E, Pestronk A, Walter M, Paradas C, Stojkovic T, Mori-Yoshimura M, Bravver E, Pegoraro E, Mendell J, Consortium J, Bushby K, Straub V. LIMB-GIRDLE MUSCULAR DYSTROPHY I. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
26
|
Selby V, Ricotti V, Mayhew A, Ridout D, Pitchforth J, Niks E, Servais L, de Groot I, Straub V, Mercuri E, Muntoni F. DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
27
|
James M, Mayhew A, Jacobs M, Spuler S, Day J, Jones K, Bharucha-Goebel D, Salort-Campana E, Pestronk A, Walter M, Paradas C, Stojkovic T, Mori-Yoshimura M, Bravver E, Diaz Manera J, Pegoraro E, Mendell J, Bushby K, Straub V. LIMB-GIRDLE MUSCULAR DYSTROPHY I. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
28
|
Hung J, Mayhew A, Welch V, Pottie K. 4.10-P9The effectiveness of Hepatitis B/C testing and linkage-to-care for migrant populations: a mixed methods systematic review. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky048.148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- J Hung
- School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, Canada
- Department of Family Medicine, McMaster University, Canada
| | - A Mayhew
- Bruyère Research Institute, Canada
| | - V Welch
- School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, Canada
- Bruyère Research Institute, Canada
- Centre for Global Health, University of Ottawa, Canada
| | - K Pottie
- School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, Canada
- Bruyère Research Institute, Canada
- Centre for Global Health, University of Ottawa, Canada
- Department of Family Medicine, University of Ottawa, Canada
| |
Collapse
|
29
|
Pitchforth J, Domingos J, Iodice M, Mayhew A, Muntoni F. Determination of the minimal clinically important difference (MCID) for clinical trial outcome measures in Duchenne Muscular Dystrophy (DMD). Neuromuscul Disord 2018. [DOI: 10.1016/s0960-8966(18)30340-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
30
|
James M, Jacobs M, Mayhew A, Feng J, Spuler S, Day J, Jones K, Bharucha-Goebel D, Salort-Campana E, Pestronk A, Walter M, Paradas C, Stojkovic T, Mori-Yoshimura M, Bravver E, Diaz Manera J, Pegoraro E, Mendell J, Bushby K, Straub V. Clinical Outcome Study of Dysferlinopathy: what are the best outcome measures for dysferlinopathy patients? Neuromuscul Disord 2018. [DOI: 10.1016/s0960-8966(18)30306-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
31
|
Jimenez-Moreno A, Nikolenko N, Moat D, Mayhew A, Massey C, Gorman G, Newman J, Kierkegaard M, Atalaia A, Turner C, Lochmüller H. Getting ready for clinical trials in myotonic dystrophy type 1 with the validation of functional outcome measures. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
32
|
Domingos J, Eagle M, Moraux A, Butler J, Decostre V, Ridout D, Mayhew A, Selby V, Guglieri M, Van der Holst M, Jansen M, Verschuuren J, de Groot I, Niks E, Servais L, Hogrel J, Straub V, Voit T, Ricotti V, Muntoni F. Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant patients: implications for clinical trials. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
33
|
Moat D, Jimenez-Moreno C, Mayhew A, Massey C, Nikolenko N, Turner C, Lochmüller H. Validity of the 6 minute walking test in myotonic dystrophy type 1 in a large scale cross-sectional study. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
34
|
James M, Mayhew A, Eagle M, Muni Lofra R, Maron E, Gee R, Harman M, Duong T, Vandevelde B, Siener C, Thiele S, Mendez J, Canal A, Sakamoto C, Holsten S, Pedrosa-Hernández I, Semplicini C, Lowes L, Bushby K, Straub V. North Star Assessment for dysferlinopathy: Longitudinal performance in the clinical outcome study of dysferlinopathy. Neuromuscul Disord 2017. [DOI: 10.1016/j.nmd.2017.06.191] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
35
|
Moreira S, Wood L, Marini-Bettolo C, Guglieri M, McMacken G, Bailey G, Mayhew A, Muni R, Eglon G, Smith D, Williams M, Lochmüller H, Evangelista T. Respiratory involvement in Facioscapulohumeral Dystrophy. Neuromuscul Disord 2017. [DOI: 10.1016/s0960-8966(17)30244-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
36
|
James M, Mayhew A, Eagle M, Moore U, Muni Lofra R, Hilsden H, Bettinson K, Harris E, Straub V, Bushby K. Development of a robust disease specific functional measure suitable for trials in ambulant and non-ambulant individuals with dysferlinopathy. Neuromuscul Disord 2017. [DOI: 10.1016/s0960-8966(17)30249-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
37
|
Díaz-Manera J, Fernandez-Torrón R, Llauger J, James M, Mayhew A, Smith F, Rufibach L, Bushby K, Straub V. Semi-quantitative muscle MRI in dysferlinopathy patients: pattern recognition and implications for clinical trials. Neuromuscul Disord 2017. [DOI: 10.1016/s0960-8966(17)30258-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
38
|
Paradas C, Moore U, James M, Mayhew A, Azzabou N, Fernandez Torron R, Reyngoudt H, Smith F, Harris E, Bettinson K, Hilsden H, Jacobs M, Feng J, Cnaan A, Rufibach L, Eagle M, Blamire A, Carlier P, Bushby K. Clinical outcome study for dysferlinopathy: One-year follow-up. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.029] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
39
|
Domingos J, Eagle M, Moraux A, Butler J, Decostre V, Ridout D, Mayhew A, Selby V, Guglieri M, Van der Holst M, Jansen M, Verschuuren J, de Groot I, Niks E, Servais L, Hogrel J, Straub V, Voit T, Ricotti V, Muntoni F. Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Ramsey D, Scoto M, Mayhew A, Main M, Mazzone E, Montes J, Dunaway S, Salazar R, Glanzman A, Pasternak A, Duong T, Gee R, Civitello M, Bushby K, Day J, Darras B, De Vivo D, Finkel R, Mercuri E, Muntoni F. Revised Hammersmith scale for spinal muscular atrophy: Longitudinal changes over six and twelve months in a large international cohort. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
41
|
Colquhoun HL, Helis E, Lowe D, Belanger D, Hill S, Mayhew A, Taylor M, Grimshaw JM. Development of training for medicines-oriented policymakers to apply evidence. Health Res Policy Syst 2016; 14:57. [PMID: 27473051 PMCID: PMC4966170 DOI: 10.1186/s12961-016-0130-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2015] [Accepted: 07/03/2016] [Indexed: 11/27/2022] Open
Abstract
Background Health systems globally promote appropriate prescribing by healthcare providers and safe and effective medicine use by consumers. Rx for Change, a publicly available database, provides access to systematic reviews regarding best practices for prescribing and using medicines. Despite the value of the database for improving prescribing and medicine use, its use remains suboptimal. This study aimed to develop a training program for five medicine-focused organisations in Canada and Australia to facilitate the use and understanding of the Rx for Change database. Methods Four steps were undertaken: 1) key informant interviews were completed across all organisations to understand the knowledge user perspective; 2) a directed content analysis was completed of the interview transcripts and proposed training was developed; 3) a second round of feedback on the proposed training by knowledge users was gathered; and 4) feedback was integrated to develop the final training. Results Sixteen key informant interviews with knowledge users were conducted. Themes for training content included the scope of, navigation and strategies for using Rx for Change (generic content) and practical examples on incorporating evidence within their workplace context (tailored content). The final training consisted of an informational video, a 60-minute face-to-face workshop and two post-training reminders. Conclusions A method of engaging knowledge users in the development of a training program to improve the use of an on-line database of systematic reviews was established and used to design training. Next steps include the delivery and evaluation of the training.
Collapse
Affiliation(s)
- H L Colquhoun
- Department of Occupational Science and Occupational Therapy, University of Toronto, 160-500 University Ave, Toronto, ON, M5G 1V7, Canada.
| | - E Helis
- Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Ottawa, ON, K1S 5S8, Canada
| | - D Lowe
- Centre for Health Communication and Participation, School of Psychology and Public Health, College of Science, Health and Engineering, La Trobe University, Melbourne, Australia
| | - D Belanger
- Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Ottawa, ON, K1S 5S8, Canada
| | - S Hill
- Centre for Health Communication and Participation, School of Psychology and Public Health, College of Science, Health and Engineering, La Trobe University, Melbourne, Australia
| | - A Mayhew
- C.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute, 43 Bruyère Street, Annex E - 208, Ottawa, ON, K1N 5C8, Canada
| | - M Taylor
- Public Health, School of Allied Health, Australian Catholic University, Fitzroy, VIC, 3065, Australia
| | - J M Grimshaw
- C.T. Lamont Primary Health Care Research Centre, Bruyère Research Institute, 43 Bruyère Street, Annex E - 208, Ottawa, ON, K1N 5C8, Canada.,Department of Medicine, University of Ottawa, School of Epidemiology, Public Health and Preventive Medicine, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada
| |
Collapse
|
42
|
Sohani ZN, Sarma S, Alyass A, de Souza RJ, Robiou-du-Pont S, Li A, Mayhew A, Yazdi F, Reddon H, Lamri A, Stryjecki C, Ishola A, Lee YK, Vashi N, Anand SS, Meyre D. Empirical evaluation of the Q-Genie tool: a protocol for assessment of effectiveness. BMJ Open 2016; 6:e010403. [PMID: 27288371 PMCID: PMC4908888 DOI: 10.1136/bmjopen-2015-010403] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
INTRODUCTION Meta-analyses of genetic association studies are affected by biases and quality shortcomings of the individual studies. We previously developed and validated a risk of bias tool for use in systematic reviews of genetic association studies. The present study describes a larger empirical evaluation of the Q-Genie tool. METHODS AND ANALYSIS MEDLINE, Embase, Global Health and the Human Genome Epidemiology Network will be searched for published meta-analyses of genetic association studies. Twelve reviewers in pairs will apply the Q-Genie tool to all studies in included meta-analyses. The Q-Genie will then be evaluated on its ability to (i) increase precision after exclusion of low quality studies, (ii) decrease heterogeneity after exclusion of low quality studies and (iii) good agreement with experts on quality rating by Q-Genie. A qualitative assessment of the tool will also be conducted using structured questionnaires. DISCUSSION This systematic review will quantitatively and qualitatively assess the Q-Genie's ability to identify poor quality genetic association studies. This information will inform the selection of studies for inclusion in meta-analyses, conduct sensitivity analyses and perform metaregression. Results of this study will strengthen our confidence in estimates of the effect of a gene on an outcome from meta-analyses, ultimately bringing us closer to deliver on the promise of personalised medicine. ETHICS AND DISSEMINATION An updated Q-Genie tool will be made available from the Population Genomics Program website and the results will be submitted for a peer-reviewed publication.
Collapse
Affiliation(s)
- Z N Sohani
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
- Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - S Sarma
- DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - A Alyass
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - R J de Souza
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - S Robiou-du-Pont
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - A Li
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - A Mayhew
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - F Yazdi
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - H Reddon
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - A Lamri
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - C Stryjecki
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - A Ishola
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - Y K Lee
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - N Vashi
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
| | - S S Anand
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada
| | - D Meyre
- Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada
- Chanchalani Research Centre, McMaster University, Hamilton, Ontario, Canada
- Department of Pathology & Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
- Faculté de Médecine, Inserm U-954, University of Lorraine and University Hospital Center of Nancy, Nancy, France
| |
Collapse
|
43
|
Jimenez C, Moreno, Eagle M, Mayhew A, James M, Straub V, Bushby K. Impact of three decades of improvement in standards of care for Duchenne muscular dystrophy. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.066] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
44
|
Ramsey D, Scoto M, Mayhew A, Ramdharry G, Wallace A, Muntoni F. Revised Hammersmith scale for spinal muscular atrophy: Inter and intra-rater reliability and content validity from a patient perspective. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
45
|
Klingels K, Mayhew A, Mazzone E, Main M, Decostre V, van den Hauwe M, Eagle M, Duong T, de Groot I, Ricotti V, Werlauff U, Campion G, Vroom E, Mercuri E, Goemans N. Development of a patient-reported outcome measure for arm and hand function in Duchenne muscular dystrophy (UL-PROM DMD). Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
46
|
Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Dunaway S, Pasternak A, Salazar R, Bushby K, Finkel R, Mercuri E, Muntoni F. Revised Hammersmith scale for spinal muscular atrophy. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
47
|
Mayhew A, James M, Eagle M, Bladen C, Muni Lofra R, Bettinson K, Hilsden H, Harris E, Bushby K, Rufibach L. Preparation of a disease specific functional measure suitable for trials in dysferlinopathy. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
48
|
Ye W, Fifield MC, Mayhew A, Nasser S, Östör AJK. Successful tocilizumab desensitization in an adult with juvenile idiopathic arthritis. Scand J Rheumatol 2015; 45:75-76. [DOI: 10.3109/03009742.2015.1074279] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
49
|
Harris E, Bettinson K, James M, Mayhew A, Eagle M, Bushby K. G.P.247. Neuromuscul Disord 2014. [DOI: 10.1016/j.nmd.2014.06.323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
50
|
Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Bushby K, Finkel R, Mercuri E, Muntoni F. P74 Improving standards of care and translational research in spinal muscular atrophy (SMA) – functional scales. Neuromuscul Disord 2014. [DOI: 10.1016/s0960-8966(14)70090-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|